Comparison of gastro‐oesophageal junction carcinomas in Chinese versus American patients

Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Robert D. Odze(Tufts Medical Center), Gregory Y. Lauwers(Moffitt Cancer Center), Lihua Zhang(Soochow University), Huiping Yu(Nanjing Drum Tower Hospital), Xiangshan Fan(Anhui Medical University), An‐Ning Feng(Nanjing Drum Tower Hospital), Agoston T. Agoston(Brigham and Women's Hospital)

Histopathology

August 1, 2011

10.1111/j.1365-2559.2011.03924.x

Cited by 56

Related Papers

Eosinophilic esophagitis: Updated consensus recommendations for children and adults

|Journal of Allergy and Clinical Immunology|2011|2.1k

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

|Nature Medicine|2004|2k

SCENIC International Consensus Statement on Surveillance and Management of Dysplasia in Inflammatory Bowel Disease

|Gastroenterology|2015|765

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study

|Journal of Clinical Oncology|2009|507